N-methyl-D-aspartate-receptor blockade
Showing 1 - 25 of >10,000
Therapy of Anti-NMDAR Encephalitis at Diagnosis
Active, not recruiting
- Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
-
Rotterdam, NetherlandsErasmus Medical Center
Sep 4, 2023
Developing Advanced Neuroimaging for Clinical Evaluation of
Recruiting
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis
- Autoimmune Encephalitis
- Not applicable - non-interventional study
-
London, Greater London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Jun 14, 2022
Clinical-immunological Features of Anti-NMDAR Encephalitis
Active, not recruiting
- Anti NMDA Receptor Encephalitis
- Description of clinical characteristic
-
Lyon, Bron, FranceHôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
Feb 12, 2023
Psycho-social Impact of Anti-NMDAR Encephalitis
Not yet recruiting
- NMDAR Antibody-associated Auto-immune Encephalitis
- standardized and validated surveys
-
Bron, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 13, 2023
Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)
Recruiting
- Anti-NMDAR Encephalitis
- IA session
- Rituximab
-
Paris, FranceHôpital Necker Enfants-Malades
Oct 31, 2022
Diagnostic Score for Encephalitis to Assess Risk of Autoimmune
Recruiting
- Autoimmune Encephalitis
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
- Clinical score of Granillo and al.
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023
GWAS in NMDAR Encephalitis
Recruiting
- Autoimmune Encephalitis
- GWAS
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 4, 2022
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)
Not yet recruiting
- NMDAR Autoimmune Encephalitis
- LGI1 Autoimmune Encephalitis
- Satralizumab
- Placebo
-
Prague, Czechia
- +1 more
Aug 15, 2022
Learning and Memory in Healthy Individuals and Those With Psychiatric Illness Trial in Chicago (GLYX-13, Placebo)
Terminated
- Learning and Memory in Healthy Individuals and Those With Psychiatric Illness
- GLYX-13
- Placebo
-
Chicago, IllinoisNorthwestern University
Jan 14, 2022
Emergence Agitation Trial in Shanghai (Esketamine, Sevoflurane)
Recruiting
- Emergence Agitation
-
Shanghai, Shanghai, ChinaAnesthesiology Department of Affiliated Eye and ENT Hospital, Fu
Dec 3, 2022
Paraneoplastic Neurologic Encephalitis and Mature Cystic
Recruiting
- Ovarian Dermoid Cyst
- Blood sample
-
Rishon LeZion, IsraelShamir medical center
Jan 23, 2022
Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)
Not yet recruiting
- Depressive Disorder
- +4 more
- Perampanel 6 MG
- +2 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Mar 14, 2023
Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)
Not yet recruiting
- Schizophrenia
- NMDAE
- Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Sep 4, 2023
Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)
Not yet recruiting
- Preemptive Analgesia
- +5 more
- Dexmedetomidine
- +2 more
-
Kafr Ash Shaykh, Karelsheikh, EgyptKarelsheikh University Hospital
Apr 19, 2023
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,
Active, not recruiting
- Breast Cancer
- +2 more
- Paclitaxel
- +4 more
-
Brasschaat, Belgium
- +53 more
Nov 29, 2022
Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)
Not yet recruiting
- Magnesium
- Intraoperative Analgesia
- Magnesium Sulfate
- Propofol
- (no location specified)
Nov 12, 2023
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022
Treatment Resistant Schizophrenia Trial in Bhubaneswar (Dextromethorphan, Placebo)
Not yet recruiting
- Treatment Resistant Schizophrenia
- Dextromethorphan
- Placebo
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Jul 15, 2023
Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)
Completed
- Postoperative Pain
- Magnesium Sulfate
- normal saline isotonic solution
-
Denizli, TurkeyPamukkale Univercity Medical School
May 25, 2023
Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)
Suspended
- Disorder of Consciousness
- Traumatic Brain Injury
- Amantadine + L-DOPA
- NMDA blocker
-
New York, New YorkWeill Cornell Medicine
Sep 27, 2022
Schizophrenia, Schizo Affective Disorder Trial in New York (D-serine, Placebo)
Not yet recruiting
- Schizophrenia
- Schizo Affective Disorder
- D-serine
- Placebo
-
New York, New YorkNew York State Psychiatric
Jul 25, 2022
Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine)
Not yet recruiting
- Scoliosis Correction
- +4 more
-
Beijing, Beijing, ChinaBeijing University First Hospital
Oct 17, 2023
Postoperative Pain, Acute, Anaesthetic Trial in Jinan (sodium chloride (NaCl; 0.9%), S-ketamine)
Recruiting
- Postoperative Pain, Acute
- Anaesthetic
- sodium chloride (NaCl; 0.9%)
- S-ketamine
-
Jinan, Shandong, ChinaQianfoshan Hospital, The First Hospital affiliated of Shandong F
Dec 9, 2022
S-ketamine, Postoperative Analgesia, Spine Fusion Trial in Beijing (S-ketamine, Placebo)
Recruiting
- S-ketamine
- +2 more
- S-ketamine
- Placebo
-
Beijing, Beijing, ChinaBeijing University First Hospital
Apr 19, 2022
Preoperative Ketamine Nebulization on Postoperative Sore Throat
Not yet recruiting
- Post Operative Sore Throat
- Ketamine
- saline nebulization
- (no location specified)
Jul 27, 2023